Skip to main content
Hit enter to search or ESC to close
Close Search
Critical Path Rare Disease App
Menu
  • Home
  • Development
  • COAs in Resource
  • Additional Information
  • Frequently Asked Questions
  • About the Consortium

COA Search

Close Search

FDA Resources

  • Clinical Outcome Assessment (COA): Frequently Asked Questions
  • Clinical Outcome Assessment Compendium
  • Condition-Specific Meeting Reports and Other Information Related to Patients’ Experience
  • Assessment of the Use of Patient Experience Data in Regulatory Decision-Making
  • Multiple Endpoints in Clinical Trials Guidance for Industry
  • FDA Patient-Focused Drug Development Guidance Series
  • FDA Drug Development Resources for the Rare Disease Community and More
  • Search for FDA Guidance Documents

 

EMA Resources

  • General Principles EMA-FDA Parallel Scientific Advice
  • Reflection Paper on Health Related Quality of Life

International Rare Diseases Research Consortium

  • Patient-Centered Outcome Measures Initiatives in the Field of Rare Diseases

National Health Council COA

Webinar Series

ISOQOL eLearning

Visit Website

COSMIN

Visit Website

ePROVIDE

Visit Website

  • Home
  • Development
  • COAs in Resource
  • Additional Information
  • Frequently Asked Questions
  • About the Consortium
  • twitter
  • facebook
  • linkedin
  • youtube

Last updated: October 25, 2023 6:29 am

© 2025 Critical Path Rare Disease App.

Close Menu
  • Home
  • Development
  • COAs in Resource
  • Additional Information
  • Frequently Asked Questions
  • About the Consortium